Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Adult mesenchymal stem cell therapy for myelin repair in multiple sclerosis.

Rivera FJ, Aigner L.

Biol Res. 2012;45(3):257-68. doi: 10.4067/S0716-97602012000300007. Review.

2.

The remyelination Philosopher's Stone: stem and progenitor cell therapies for multiple sclerosis.

Jadasz JJ, Aigner L, Rivera FJ, Küry P.

Cell Tissue Res. 2012 Jul;349(1):331-47. doi: 10.1007/s00441-012-1331-x. Epub 2012 Feb 10. Review.

PMID:
22322424
3.

Therapeutic effect of transplanted human Wharton's jelly stem cell-derived oligodendrocyte progenitor cells (hWJ-MSC-derived OPCs) in an animal model of multiple sclerosis.

Mikaeili Agah E, Parivar K, Joghataei MT.

Mol Neurobiol. 2014 Apr;49(2):625-32. doi: 10.1007/s12035-013-8543-2. Epub 2013 Aug 28.

PMID:
23982748
4.

Cells of the oligodendroglial lineage, myelination, and remyelination.

Miron VE, Kuhlmann T, Antel JP.

Biochim Biophys Acta. 2011 Feb;1812(2):184-93. doi: 10.1016/j.bbadis.2010.09.010. Epub 2010 Sep 29. Review.

5.

Mesenchymal stem cells do not exert direct beneficial effects on CNS remyelination in the absence of the peripheral immune system.

Salinas Tejedor L, Berner G, Jacobsen K, Gudi V, Jungwirth N, Hansmann F, Gingele S, Prajeeth CK, Baumgärtner W, Hoffmann A, Skripuletz T, Stangel M.

Brain Behav Immun. 2015 Nov;50:155-165. doi: 10.1016/j.bbi.2015.06.024. Epub 2015 Jun 30.

PMID:
26140734
6.

Neurotrophin-3 gene modified mesenchymal stem cells promote remyelination and functional recovery in the demyelinated spinal cord of rats.

Zhang YJ, Zhang W, Lin CG, Ding Y, Huang SF, Wu JL, Li Y, Dong H, Zeng YS.

J Neurol Sci. 2012 Feb 15;313(1-2):64-74. doi: 10.1016/j.jns.2011.09.027. Epub 2011 Oct 13.

PMID:
21996274
7.

The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS.

Reynolds R, Dawson M, Papadopoulos D, Polito A, Di Bello IC, Pham-Dinh D, Levine J.

J Neurocytol. 2002 Jul-Aug;31(6-7):523-36.

PMID:
14501221
8.

Beneficial effects of bone marrow-derived mesenchymal stem cell transplantation in a non-immune model of demyelination.

El-Akabawy G, Rashed LA.

Ann Anat. 2015 Mar;198:11-20. doi: 10.1016/j.aanat.2014.12.002. Epub 2015 Jan 20.

PMID:
25660362
9.

[Novel remyelination strategy for multiple sclerosis in the era of oligodendrocytopathy].

Nakahara J.

Rinsho Shinkeigaku. 2012;52(11):1351-3. Japanese.

PMID:
23196615
10.

Mesenchymal stem cells enhance the engraftment and myelinating ability of allogeneic oligodendrocyte progenitors in dysmyelinated mice.

Cristofanilli M, Harris VK, Zigelbaum A, Goossens AM, Lu A, Rosenthal H, Sadiq SA.

Stem Cells Dev. 2011 Dec;20(12):2065-76. doi: 10.1089/scd.2010.0547. Epub 2011 Mar 12.

PMID:
21299379
11.

Remyelination therapy for multiple sclerosis.

Keough MB, Yong VW.

Neurotherapeutics. 2013 Jan;10(1):44-54. doi: 10.1007/s13311-012-0152-7. Review.

12.

Mesenchymal stem cell conditioning promotes rat oligodendroglial cell maturation.

Jadasz JJ, Kremer D, Göttle P, Tzekova N, Domke J, Rivera FJ, Adjaye J, Hartung HP, Aigner L, Küry P.

PLoS One. 2013 Aug 12;8(8):e71814. doi: 10.1371/journal.pone.0071814. eCollection 2013.

13.

Oligodendrogenesis from neural stem cells: perspectives for remyelinating strategies.

Grade S, Bernardino L, Malva JO.

Int J Dev Neurosci. 2013 Nov;31(7):692-700. doi: 10.1016/j.ijdevneu.2013.01.004. Epub 2013 Jan 20. Review.

PMID:
23340483
14.

Remyelination in multiple sclerosis.

Chari DM.

Int Rev Neurobiol. 2007;79:589-620. Review.

PMID:
17531860
15.

The complex world of oligodendroglial differentiation inhibitors.

Kremer D, Aktas O, Hartung HP, Küry P.

Ann Neurol. 2011 Apr;69(4):602-18. doi: 10.1002/ana.22415. Review.

PMID:
21520230
16.

Clinical and pathological effects of intrathecal injection of mesenchymal stem cell-derived neural progenitors in an experimental model of multiple sclerosis.

Harris VK, Yan QJ, Vyshkina T, Sahabi S, Liu X, Sadiq SA.

J Neurol Sci. 2012 Feb 15;313(1-2):167-77. doi: 10.1016/j.jns.2011.08.036. Epub 2011 Oct 1.

PMID:
21962795
17.

Characterization of autologous mesenchymal stem cell-derived neural progenitors as a feasible source of stem cells for central nervous system applications in multiple sclerosis.

Harris VK, Faroqui R, Vyshkina T, Sadiq SA.

Stem Cells Transl Med. 2012 Jul;1(7):536-47. doi: 10.5966/sctm.2012-0015. Epub 2012 Jun 28.

18.

Cellular approaches for stimulating CNS remyelination.

Miller RH, Bai L.

Regen Med. 2007 Sep;2(5):817-29. Review.

PMID:
17907933
19.

Remyelinating strategies for the treatment of multiple sclerosis.

Stangel M, Hartung HP.

Prog Neurobiol. 2002 Dec;68(5):361-76. Review.

PMID:
12531235
20.

Remyelination induced by a DNA aptamer in a mouse model of multiple sclerosis.

Nastasijevic B, Wright BR, Smestad J, Warrington AE, Rodriguez M, Maher LJ 3rd.

PLoS One. 2012;7(6):e39595. doi: 10.1371/journal.pone.0039595. Epub 2012 Jun 27.

Supplemental Content

Support Center